Depression(stherapie) – ein Feld der Integration?

Henning Schauenburg

doi:10.1055/a-1215-1541

PiD - Psychotherapie im Dialog, Table of Contents

PiD - Psychotherapie im Dialog 2021; 22(03): 17-23
DOI: 10.1055/a-1215-1541

Standpunkte

Depression(stherapie) – ein Feld der Integration?

Henning Schauenburg

Abstract

Wer hätte gedacht, dass uns die Wirklichkeit auf eine solche Weise mit dem Thema Depression konfrontieren würde, wie es durch die Corona-Pandemie geschieht? Viele Menschen sind Belastungen ausgesetzt, haben berufliche und familiäre Sorgen, Zukunftsängste – typische Faktoren, die ein Anwachsen depressiver Erkrankungen erwarten lassen.

Full Text

References

Literatur
1 Damerow S, Rommel A, Prütz F. et al. Die gesundheitliche Lage in Deutschland in der Anfangsphase der COVID-19-Pandemie. Zeitliche Entwicklung ausgewählter Indikatoren der Studie GEDA 2019/2020-EHIS. Journal of Health Monitoring 2020; 5 (04) 3-22
2 Hapke U, Cohrdes C, Nübel J. Depressive Symptomatik im europäischen Vergleich – Ergebnisse des European Health Interview Survey (EHIS) 2. J Health Monitoring 2019; 4 (04) 62-70
3 Global Burden of Diseases: Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392: 1789-1858 Epub 2018 Nov 8
4 Statistisches Bundesamt. https://www.destatis.de/DE/Themen/Gesellschaft-Umwelt/Gesundheit/Todesursachen/Tabellen/suizide.html
5 Twenge JM, Martin GN, Campbell WK. Decreases in psychological well-being among American adolescents after 2012 and links to screen time during the rise of smartphone technology. Emotion 2018; 18: 765-780
6 Wang Y, Kala MP, Jafar TH. Factors associated with psychological distress during the coronavirus disease 2019 (COVID-19) pandemic on the predominantly general population: A systematic review and meta-analysis. PLoS One 2020; 15 (12) 0
7 Beck AT, Bredemeier KA. unified model of depression: Integrating clini-cal, cognitive, biological, and evolutionary perspectives. Clin Psychol Sci 2016; 4 (04) 596-619
8 Hoffmann A, Sportelli V, Ziller M. et al. Epigenomics of Major Depressive Disorders and Schizophrenia: Early Life Decides. Int J Mol Sci 2017; 18 (08) 1711
9 Moore SR, Depue RA. Neurobehavioral foundation of environmental reactivity. Psychol Bull 2016; 142 (02) 107-64
10 Benedetti F, Riccaboni R, Poletti S. et al. The serotonin transporter genotype modulates the relationship between early stress and adult suicidality in bipolar disorder. Bipolar Disord 2014; 16 (08) 857-66
11 Caspi A, Sugden K, Moffitt TE. et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003; 301: 386-389
12 Border R, Johnson EC, Evans LM. et al. No Support for Historical Candidate Gene or Candidate Gene-by-Interaction Hypotheses for Major Depression Across Multiple Large Samples. Am J Psychiatry 2019; 176 (05) 376-387
13 Schauenburg H. Depression und Bindung – Therapeutische Strategien. Göttingen: Vandenhoeck und Ruprecht; 2018
14 Fearon P, Shmueli-Goetz Y, Viding E. et al. Genetic and environmental influences on adolescent attachment. J Child Psychol Psychiatry 2014; 55 (09) 1033-1041
15 Cipriani A, Furukawa TA, Salanti G. et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 2018; 391: 1357-1366
16 Bschor T, Hullmeine L. Pharmakotherapie der Depression - neue Erkenntnisse und neue Strategien. PiD – Psychotherapie im Dialog 2021; 22 (03) 49-53
17 Kappelmann N, Arloth J, Georgakis MK. et al. Dissecting the Association Between Inflammation, Metabolic Dysregulation, and Specific Depressive Symptoms: A Genetic Correlation and 2-Sample Mendelian Randomization Study. JAMA Psychiatry 2021; 78: 161-170
18 Maslej MM, Furukawa TA, Cipriani A. et al. Individual Differences in Response to Antidepressants: A Meta-analysis of Placebo-Controlled Randomized Clinical Trials. JAMA Psychiatry 2021; 78: 490-497
19 Reiff CM, Richman EE, Nemeroff CB. et al. the Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research. Psychedelics and Psychedelic-Assisted Psychotherapy. Am J Psychiatry 2020; 177: 391-410
20 Davis AK, Barrett FS, May DG. et al. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. JAMA Psychiatry 2021; 78: 481-489
21 Cuijpers P, Karyotaki E, de Wit L. et al. The effects of fifteen evidence-supported therapies for adult depression: A meta-analytic review. Psychother Res 2020; 30: 279-293
22 Schwartz B, Cohen ZD, Rubel JA. et al. Personalized treatment selection in routine care: Integrating machine learning and statistical algorithms to recommend cognitive behavioral or psychodynamic. therapy, Psychother Res 2021; 31 (01) 33-51 Epub 2020 May 28
23 Driessen E, Hegelmaier LM, Abbass AA. et al. The efficacy of short-term psychodynamic psychotherapy for depression: A meta-analysis update. Clin Psychol Rev 2015; 42: 1-15
24 Høstmælingen A, Ulvenes P, Nissen-Lie A. et al. Comparing outcomes in chronic depression following inpatient psychotherapy for patients continuing versus discontinuing antidepressant medication. Clin Psychol Psychother. 2021
25 Rost F, Luyten P, Fearon P. et al. Personality and outcome in individuals with treatment-resistant depression-Exploring differential treatment effects in the Tavistock Adult Depression Study (TADS). J Consult Clin Psychol 2019; 87: 433-445
26 Leuzinger-Bohleber M, Hautzinger M, Fiedler G. et al. Outcome of Psychoanalytic and Cognitive-Behavioural Long-Term Therapy with Chronically Depressed Patients: A Controlled Trial with Preferential and Randomized Allocation. Can J Psychiatry 2019; 64: 47-58
27 Multmeyer J. Ambulante psychotherapeutische Versorgung in Deutschland – eine Kohortenbetrachtung der KBV. Projekt Psychotherapie 2014; 2: 12-22
28 Young JE, Klosko JS, Weishaar ME. Schematherapie. Ein praxisorientiertes Handbuch. Paderorn: Junfermann Verlag; 2008
29 Backenstrass M. Neuere Ansätze in der Psychotherapie der chronischen Depression. PiD – Psychotherapie im Dialog 2021; 22 (03) 24-28
30 Hayes SC, Strosahl KD, Wilson KG. Akzeptanz und Commitment Therapie. Ein erlebnisorientierter Ansatz zur Verhaltensänderung. München: CIP-Medien; 2004
31 Greenberg LS, Watson JC. Emotion-focused therapy for depression. Washington, DC: American Psychological Association; 2005
32 Bateman AW, Fonagy P. Psychotherapie der Borderline Persönlichkeitsstörung. Ein mentalisierungsgestütztes Behandlungskonzept. Gießen: Psychosozialverlag; 2008
33 Rudolf G. Strukturbezogene Psychotherapie. 4 Aufl.. Stuttgart: Schattauer; 2020
34 Schauenburg H, Teismann T. Psychotherapie der Depression. In: Senf W, Broda M. Hrsg. Lehrbuch der Psychotherapie. 4. Aufl.. Stuttgart: Thieme; 2020: 481-509
35 Dinger U, Schauenburg H. Therapie depressiver Störungen. In: Rief W, Schramm E, Strauß B. Hrsg. Psychologische Psychotherapie. München: Elsevier; 2021: 77-94
36 Tyrer P. Personality disorder: Good reasons to reclassify. Aust N Z J Psychiatry 2017; 51: 1077-1078
37 Meyer G, Schultz J-H. Depression per App behandeln? Möglichkeiten und Grenzen digitaler Gesundheitsanwendungen (DiGAs). PiD – Psychotherapie im Dialog 2021; 22 (03) 54-58
38 Huber J, Jennissen S, Nikendei C. et al. Agency and Alliance as Mechanisms of Change in Psychotherapy. J Consul Clin Psychol 2021; 89: 214-226
39 Safran JD, Muran JC, Eubanks-Carter C. Repairing alliance ruptures. Psychotherapy 2011; 48: 80-87
40 Zilcha-Mano S, Goldstein P, Dolev-Amit T. et al. Oxytocin synchrony between patients and therapists as a mechanism underlying effective psychotherapy for depression. J Consult Clin Psychol 2021; 89: 49-57